Fast Five Quiz: Management of Systemic Sclerosis Interstitial Lung Disease

Zab Mosenifar, MD


March 28, 2023

Systemic sclerosis (SSc) is a collagen tissue disorder (CTD) characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. Fibrosing interstitial lung disease (ILD) is a common manifestation of SSc, leading to exertional dyspnea and restrictive lung disease with eventual respiratory failure. ILD is the most common cause of death in patients with SSc, with a 10-year mortality of up to 40%. Diagnosis of SSc-ILD is based on high-resolution CT (HRCT) findings in a patient with known SSc, along with normal or abnormal pulmonary function tests (PFTs). In most cases, the goal of treatment is to achieve disease stabilization.

Are you up-to-date on the management of SSc-ILD? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.